Premium Access
Register / Login
Home
News
Live
Latest
International
Explainers
Obituary
Politics
Photo Stories
Interactives
Exclusive
Analysis
States
North
Delhi
Bihar
Haryana
Himachal Pradesh
Jammu and Kashmir
Madhya Pradesh
Punjab
Uttar Pradesh
Uttarakhand
Ladakh
South
Andhra Pradesh
Goa
Karnataka
Kerala
Puducherry
Tamil Nadu
Telangana
East
Chhattisgarh
Jharkhand
Odisha
West Bengal
West
Gujarat
Maharashtra
Rajasthan
North-East
Arunachal Pradesh
Assam
Manipur
Meghalaya
Mizoram
Nagaland
Sikkim
Tripura
Perspective
Opinion
Two-Bit
Faultlines
Videos
News
Interviews
Programmes
Features
Education
Schools
Entertainment
Elections
Election 2019
Assam Elections 2021
Assembly Elections 2023
Elections 2024
Elections - Interactives
Sports
Features
Health
Budget 2024-25
Business
Budget 2023
Flight Insight
News View
Series
Bishnoi's Men
NEET TANGLE
Economy Series
Earth Day
Kashmir’s Frozen Turbulence
India@75
The legend of Ramjanmabhoomi
Liberalisation@30
How to tame a dragon
Celebrating biodiversity
Farm Matters
50 days of solitude
Bringing Migrants Home
Budget 2020
Jharkhand Votes
The Federal Investigates
The Federal Impact
Vanishing Sand
Gandhi @ 150
Andhra Today
Field report
Operation Gulmarg
Pandemic @1 Mn in India
The Federal Year-End
The Zero Year
Premium
Science
Brand studio
Newsletter
Elections 2024
Home
News
News
Live
The Federal Focus
Latest
Explainers
Politics
International
Obituary
Photo Stories
Interactives
Exclusive
Loading...
Analysis
States
States
East
West
North
South
North-East
Loading...
Perspective
Perspective
Opinion
Two-Bit
Faultlines
Loading...
Videos
Videos
News
Interviews
Programs
Feature
Loading...
Entertainment
Elections
Elections
Election 2019
Assam Elections 2021
Assembly Elections 2023
Elections 2024
Elections - Interactives
Loading...
Sports
Features
Business
Business
Flight Insight
Farm Matters
Personal Finance
Budget 2024-25
Loading...
Premium
Premium
The Eighth Column
Loading...
Elections 2024
Home
dgci
#DGCI
DCGI approves SII's Covovax vaccine as heterologous booster dose for adults
17 Jan 2023 5:57 PM IST
Covaxin gets approval for 6-12 age group
26 April 2022 6:51 PM IST
After waiver on trials, Centre may grant legal indemnity to Pfizer, others
2 Jun 2021 4:23 PM IST
DRDO's 2-DG drug for COVID patients available from next week
17 May 2021 6:30 AM IST
Covaxin: Don’t discredit science-based protocols, Vardhan tells Opposition
4 Jan 2021 8:01 AM IST
Pfizer India becomes first pharma to apply for COVID-19 vaccine use in India
6 Dec 2020 1:26 PM IST
Oxford COVID vaccine trial volunteer demands ₹5 cr for 'serious symptoms'
29 Nov 2020 7:32 PM IST
Top Stories
X